187 related articles for article (PubMed ID: 23681190)
1. Protection of vascular endothelium by aspirin in a murine model of chronic Chagas' disease.
Molina-Berríos A; Campos-Estrada C; Lapier M; Duaso J; Kemmerling U; Galanti N; Ferreira J; Morello A; López-Muñoz R; Maya JD
Parasitol Res; 2013 Jul; 112(7):2731-9. PubMed ID: 23681190
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin Attenuates Endothelial Activation through 15-Epi-Lipoxin A4 Production in Murine Chronic Chagas Cardiomyopathy.
González-Herrera F; Cramer A; Pimentel P; Castillo C; Liempi A; Kemmerling U; Machado FS; Maya JD
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993857
[TBL] [Abstract][Full Text] [Related]
3. Benznidazole prevents endothelial damage in an experimental model of Chagas disease.
Molina-Berríos A; Campos-Estrada C; Lapier M; Duaso J; Kemmerling U; Galanti N; Leiva M; Ferreira J; López-Muñoz R; Maya JD
Acta Trop; 2013 Jul; 127(1):6-13. PubMed ID: 23529066
[TBL] [Abstract][Full Text] [Related]
4. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.
Mukherjee S; Machado FS; Huang H; Oz HS; Jelicks LA; Prado CM; Koba W; Fine EJ; Zhao D; Factor SM; Collado JE; Weiss LM; Tanowitz HB; Ashton AW
PLoS One; 2011 Feb; 6(2):e16959. PubMed ID: 21347238
[TBL] [Abstract][Full Text] [Related]
5. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease.
Waghabi MC; de Souza EM; de Oliveira GM; Keramidas M; Feige JJ; Araújo-Jorge TC; Bailly S
Antimicrob Agents Chemother; 2009 Nov; 53(11):4694-701. PubMed ID: 19738024
[TBL] [Abstract][Full Text] [Related]
7. TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease.
Ferreira RR; Abreu RDS; Vilar-Pereira G; Degrave W; Meuser-Batista M; Ferreira NVC; da Cruz Moreira O; da Silva Gomes NL; Mello de Souza E; Ramos IP; Bailly S; Feige JJ; Lannes-Vieira J; de Araújo-Jorge TC; Waghabi MC
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007602. PubMed ID: 31365537
[TBL] [Abstract][Full Text] [Related]
8. Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease.
Pedra-Rezende Y; Barbosa JMC; Bombaça ACS; Dantas-Pereira L; Gibaldi D; Vilar-Pereira G; Dos Santos HAM; Ramos IP; Silva-Gomes NL; Moreira OC; Lannes-Vieira J; Menna-Barreto RFS
Front Immunol; 2021; 12():712034. PubMed ID: 34804007
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of neural cell adhesion molecule in Chagas' myocarditis.
Soler AP; Gilliard G; Xiong Y; Knudsen KA; Martin JL; De Suarez CB; Mota Gamboa JD; Mosca W; Zoppi LB
Hum Pathol; 2001 Feb; 32(2):149-55. PubMed ID: 11230701
[TBL] [Abstract][Full Text] [Related]
10. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
[TBL] [Abstract][Full Text] [Related]
11. Soluble cell adhesion molecules in human Chagas' disease: association with disease severity and stage of infection.
Laucella S; De Titto EH; Segura EL; Orn A; Rottenberg ME
Am J Trop Med Hyg; 1996 Dec; 55(6):629-34. PubMed ID: 9025689
[TBL] [Abstract][Full Text] [Related]
12. Effects of aspirin-triggered resolvin D1 on peripheral blood mononuclear cells from patients with Chagas' heart disease.
Ogata H; Teixeira MM; Sousa RC; Silva MV; Correia D; Rodrigues Junior V; Levy BD; Rogério Ade P
Eur J Pharmacol; 2016 Apr; 777():26-32. PubMed ID: 26927755
[TBL] [Abstract][Full Text] [Related]
13. A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection.
Barry MA; Versteeg L; Wang Q; Pollet J; Zhan B; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM
PLoS Negl Trop Dis; 2019 May; 13(5):e0007413. PubMed ID: 31145733
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.
Guedes PM; Oliveira FS; Gutierrez FR; da Silva GK; Rodrigues GJ; Bendhack LM; Franco DW; Do Valle Matta MA; Zamboni DS; da Silva RS; Silva JS
Br J Pharmacol; 2010 May; 160(2):270-82. PubMed ID: 20128813
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E
Hernández M; Wicz S; Corral RS
Phytomedicine; 2016 Nov; 23(12):1392-1400. PubMed ID: 27765359
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin.
Campos-Estrada C; Liempi A; González-Herrera F; Lapier M; Kemmerling U; Pesce B; Ferreira J; López-Muñoz R; Maya JD
PLoS Negl Trop Dis; 2015 May; 9(5):e0003770. PubMed ID: 25978361
[TBL] [Abstract][Full Text] [Related]
17. Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy.
Tanowitz HB; Burns ER; Sinha AK; Kahn NN; Morris SA; Factor SM; Hatcher VB; Bilezikian JP; Baum SG; Wittner M
Am J Trop Med Hyg; 1990 Sep; 43(3):274-81. PubMed ID: 2121055
[TBL] [Abstract][Full Text] [Related]
18. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy.
Bustamante JM; Rivarola HW; Fernández AR; Enders JE; Fretes R; Palma JA; Paglini-Oliva PA
Clin Sci (Lond); 2003 Apr; 104(4):415-20. PubMed ID: 12653687
[TBL] [Abstract][Full Text] [Related]
19. Treatment with low doses of aspirin during chronic phase of experimental Chagas' disease increases oesophageal nitrergic neuronal subpopulation in mice.
Massocatto CL; Martins Moreira N; Muniz E; Marques de Araújo S; Pinge-Filho P; Rossi RM; de Almeida Araújo EJ; de Mello Gonçales Sant'ana D
Int J Exp Pathol; 2017 Dec; 98(6):356-362. PubMed ID: 29349896
[TBL] [Abstract][Full Text] [Related]
20. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
Front Immunol; 2020; 11():306. PubMed ID: 32194558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
